Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Three Things To Remember During The Avandia Panel
Forbes
Monday, July 12, 2010 - 10:14am
tags:
GSK, FDA, Avandia, diabetes, advisory panels
J&J to buy Micrus Endovascular for $480 million
Marketwatch
Monday, July 12, 2010 - 10:12am
tags:
Micrus Endovascular, JNJ, M&A
Don't push big pharma off a cliff just yet
Investment News
Sunday, July 11, 2010 - 2:42pm
tags:
Big Pharma, patents, Eli Lilly, Zyprexa, Plavix, Bristol-Myers Squibb, Pfizer, Lipitor, Merck, Singulair
J&J Sued by Consumers Over Children's Cold Medicines
Bloomberg
Sunday, July 11, 2010 - 2:40pm
tags:
JNJ, lawsuits, consumers, recalls
Genentech's New Option for Breast Cancer Patients
Seeking Alpha
Sunday, July 11, 2010 - 2:31pm
tags:
Genentech, breast cancer, Immunogen, Roche, Trastuzumab-Dm1
Trading FDA, Clinical Trial Binary Events: Cumberland Pharma
Seeking Alpha
Sunday, July 11, 2010 - 2:30pm
tags:
FDA, clinical trials, Cumberland
Making the Case for Merck
Seeking Alpha
Sunday, July 11, 2010 - 2:29pm
tags:
Merck
Why Hasn't McNeil's President Resigned Over the Tylenol Recall? (Among Other Unsolved Mysteries at J&J)
BNET Pharma
Sunday, July 11, 2010 - 2:23pm
tags:
JNJ, recalls, Tylenol
India creates an impact in the pharmaceutical industry
Seer Press
Saturday, July 10, 2010 - 11:44am
tags:
India, Sun Pharma, Piramal Healthcare
Will Avandia Be Yanked Off the Market?
US News
Saturday, July 10, 2010 - 11:41am
tags:
Avandia, GSK, diabetes
SPRYCEL® (dasatinib) Receives FDA Priority Review for the Treatment of Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia (CML) in Chronic Phase
Yahoo/BusinessWire
Saturday, July 10, 2010 - 11:39am
tags:
Sprycel, chronic myeloid leukemia, BMS, Otsuka
Bright Future Seen For Vaccine Research
Investor's Business Daily
Saturday, July 10, 2010 - 11:22am
tags:
Abbott Laboratories, vaccines, GSK, AstraZeneca, Sanofi, Novartis
Hey, Johnson & Johnson: Eight Is Enough
Motley Fool
Saturday, July 10, 2010 - 11:20am
tags:
recalls, JNJ
Rodman & Renshaw lowers Vivus to 'Market Perform'
Yahoo/AP
Saturday, July 10, 2010 - 11:18am
tags:
obesity, Qnexa, Vivus
Onyx, Vivus rise on ratings boost
MarketWatch
Saturday, July 10, 2010 - 11:12am
tags:
ONYX Pharmaceuticals, Vivus
FDA Reviewer: Avandia Is Guilty
Forbes
Friday, July 9, 2010 - 3:33pm
tags:
FDA, Avandia, GSK, heart attacks
Lawyer Who Won Fosamax Case Faces Sanctions
Pharmalot
Friday, July 9, 2010 - 12:33pm
tags:
Fosamax, lawsuits, Merck
Allergan Wins U.K. Clearance to Market Botox as Treatment for Migraines
Bloomberg
Friday, July 9, 2010 - 12:31pm
tags:
Botox, UK, migraines, Allergan
Doc-payment info hits J&J unit websites
Fierce Pharma
Friday, July 9, 2010 - 12:29pm
tags:
JNJ, physician payments
Biotech Stock Mailbag: Somaxon
TheStreet.com
Friday, July 9, 2010 - 12:27pm
tags:
Somaxon, Dendreon, Arena Pharmaceuticals, Orexigen, Vivus, Roche, GSK, Immunogen

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.